Suchergebnisse - "Freedman, Arnold S"

PubPharm (128)

1

A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma

enthalten in: Annals of hematology | 2024

von Merryman, R. | Redd, R. | Freedman, A. | +22

2

Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation

enthalten in: Blood advances | 2023

von Merryman, R. | Redd, R. | Taranto, E. | +24

3

Targeting constitutively active STAT3 in chronic lymphocytic leukemia : A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses

enthalten in: American journal of hematology | 2021

von Brown, J. | Walker, S. | Heppler, L. | +17

4

Targeting constitutively active STAT3 in chronic lymphocytic leukemia : A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses

enthalten in: American Journal of Hematology | 2021

von Brown, J. | Walker, S. | Heppler, L. | +17

5

PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation

enthalten in: Blood advances | 2020

von Frigault, M. | Armand, P. | Redd, R. | +23

6

PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation

enthalten in: Blood | 2019

von Armand, P. | Chen, Y. | Redd, R. | +22

CommentIn: Blood. 2019 Jul 4;134(1):1-2. - PMID 31273001

7

Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia

enthalten in: Blood advances | 2019

von Lampson, B. | Kim, H. | Davids, M. | +13

8

Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2017

von Gibson, C. | Lindsley, R. | Tchekmedyian, V. | +26

CommentIn: J Clin Oncol. 2017 May 10;35(14):1503-1505. - PMID 28291387

9

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2017

von Herrera, A. | Mei, M. | Low, L. | +37

CommentIn: J Clin Oncol. 2017 Jan;35(1):1-3. - PMID 28034063

10

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation

enthalten in: Journal of clinical oncology / Englische Ausgabe | 2017

von Herrera, A. | Mei, M. | Low, L. | +37

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]